Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell Lymphoma.

Cudillo L, Cerretti R, Picardi A, Mariotti B, De Angelis G, Cantonetti M, Postorino M, Ceresoli E, De Santis G, Nasso D, Pisani F, Scala E, Di Piazza F, Lanti A; William Arcese for the Rome Transplant Network.

Ann Hematol. 2018 Jun;97(6):1041-1048. doi: 10.1007/s00277-018-3275-z. Epub 2018 Feb 13.

PMID:
29442161
2.

Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal.

Cerva C, Maffongelli G, Svicher V, Salpini R, Colagrossi L, Battisti A, Mariotti B, Cerretti R, Cudillo L, Sarmati L.

BMC Infect Dis. 2017 Aug 15;17(1):566. doi: 10.1186/s12879-017-2672-6.

3.

The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy.

Picardi A, Arcese W, Pollichieni S, Di Piazza F, Mangione I, Gallina AM, Cerretti R, Cudillo L, De Angelis G, Mengarelli A, Dentamaro T, Tirindelli MC, Chierichini A, Ferrari A, Marciano R, Andreani M, Bonifazi F, Sacchi N.

Transfusion. 2017 Jul;57(7):1734-1743. doi: 10.1111/trf.14131. Epub 2017 Jun 13.

PMID:
28608367
4.

Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System.

Della Porta MG, Jackson CH, Alessandrino EP, Rossi M, Bacigalupo A, van Lint MT, Bernardi M, Allione B, Bosi A, Guidi S, Santini V, Malcovati L, Ubezio M, Milanesi C, Todisco E, Voso MT, Musto P, Onida F, Iori AP, Cerretti R, Grillo G, Molteni A, Pioltelli P, Borin L, Angelucci E, Oldani E, Sica S, Pascutto C, Ferretti V, Santoro A, Bonifazi F, Cazzola M, Rambaldi A.

Leukemia. 2017 Nov;31(11):2449-2457. doi: 10.1038/leu.2017.88. Epub 2017 Mar 21.

5.

Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia.

Buccisano F, Maurillo L, Piciocchi A, Del Principe MI, Picardi A, Cerretti R, Cudillo L, De Angelis G, Sarlo C, Cefalo M, Ditto C, Di Veroli A, Mariotti B, Nasso D, De Bellis E, Del Poeta G, Voso MT, Sconocchia G, Lo Coco F, Arcese W, Amadori S, Venditti A.

Bone Marrow Transplant. 2017 Mar;52(3):473-475. doi: 10.1038/bmt.2016.308. Epub 2016 Dec 12. No abstract available.

PMID:
27941782
6.

Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor.

Cerva C, Colagrossi L, Maffongelli G, Salpini R, Di Carlo D, Malagnino V, Battisti A, Ricciardi A, Pollicita M, Bianchi A, Picardi A, Cudillo L, Cerretti R, De Angelis G, Cantonetti M, Andreoni M, Perno CF, Arcese W, Svicher V, Sarmati L.

Clin Microbiol Infect. 2016 Nov;22(11):946.e1-946.e8. doi: 10.1016/j.cmi.2016.07.021. Epub 2016 Jul 27.

7.

Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update.

Arcese W, Picardi A, Santarone S, De Angelis G, Cerretti R, Cudillo L, Pennese E, Bavaro P, Olioso P, Dentamaro T, Cupelli L, Chierichini A, Ferrari A, Mengarelli A, Tirindelli MC, Testi M, Di Piazza F, Di Bartolomeo P; Rome Transplant Network.

Bone Marrow Transplant. 2015 Jun;50 Suppl 2:S24-30. doi: 10.1038/bmt.2015.91.

PMID:
26039203
8.

Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia.

Maurillo L, Buccisano F, Piciocchi A, Del Principe MI, Sarlo C, Di Veroli A, Panetta P, Irno-Consalvo M, Nasso D, Ditto C, Refrigeri M, De Angelis G, Cerretti R, Arcese W, Sconocchia G, Lo-Coco F, Amadori S, Venditti A.

Am J Hematol. 2015 Feb;90(2):125-31. doi: 10.1002/ajh.23893. Epub 2014 Nov 24.

9.

Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.

Tirindelli MC, Flammia GP, Bove P, Cerretti R, Cudillo L, De Angelis G, Picardi A, Annibali O, Nobile C, Cerchiara E, Dentamaro T, De Fabritiis P, Lanti A, Ferraro AS, Sergi F, Di Piazza F, Avvisati G, Arcese W; Rome Transplant Network.

Biol Blood Marrow Transplant. 2014 Oct;20(10):1612-7. doi: 10.1016/j.bbmt.2014.06.018. Epub 2014 Jun 20.

10.

Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R.

Della Porta MG, Alessandrino EP, Bacigalupo A, van Lint MT, Malcovati L, Pascutto C, Falda M, Bernardi M, Onida F, Guidi S, Iori AP, Cerretti R, Marenco P, Pioltelli P, Angelucci E, Oneto R, Ripamonti F, Bernasconi P, Bosi A, Cazzola M, Rambaldi A; Gruppo Italiano Trapianto di Midollo Osseo.

Blood. 2014 Apr 10;123(15):2333-42. doi: 10.1182/blood-2013-12-542720. Epub 2014 Feb 20.

11.

Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation.

Calabrese E, Zorzi F, Visconti E, De Angelis G, Cerretti R, Del Vecchio Blanco G, Picardi A, Cudillo L, Postorino M, Franceschini L, Biancone L, Arcese W, Pallone F.

Dig Liver Dis. 2013 Nov;45(11):899-904. doi: 10.1016/j.dld.2013.04.004. Epub 2013 May 13.

PMID:
23680035
12.

Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome.

Alessandrino EP, Porta MG, Malcovati L, Jackson CH, Pascutto C, Bacigalupo A, Teresa van Lint M, Falda M, Bernardi M, Onida F, Guidi S, Iori AP, Cerretti R, Marenco P, Pioltelli P, Angelucci E, Oneto R, Ripamonti F, Rambaldi A, Bosi A, Cazzola M; Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Am J Hematol. 2013 Jul;88(7):581-8. doi: 10.1002/ajh.23458. Epub 2013 May 30.

13.

Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies.

Di Bartolomeo P, Santarone S, De Angelis G, Picardi A, Cudillo L, Cerretti R, Adorno G, Angelini S, Andreani M, De Felice L, Rapanotti MC, Sarmati L, Bavaro P, Papalinetti G, Di Nicola M, Papola F, Montanari M, Nagler A, Arcese W.

Blood. 2013 Jan 31;121(5):849-57. doi: 10.1182/blood-2012-08-453399. Epub 2012 Nov 19.

14.

Granulocyte-mobilized bone marrow.

Arcese W, De Angelis G, Cerretti R.

Curr Opin Hematol. 2012 Nov;19(6):448-53. doi: 10.1097/MOH.0b013e32835903ab. Review.

PMID:
22954729
15.

The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: a study from the Rome Transplant Network.

Marchesi F, Giannotti F, Avvisati G, Petti MC, Pimpinelli F, Paba P, Dessanti ML, Cerretti R, Tirindelli MC, Picardi A, D'Andrea M, Spadea A, Ensoli F, Perno CF, Mengarelli A, Arcese W.

Am J Hematol. 2012 Feb;87(2):213-7. doi: 10.1002/ajh.22214. Epub 2011 Nov 11.

16.

Cord blood transplantation in adults with acute myeloid leukaemia.

Arcese W, Buccisano F, Cerretti R, Picardi A; Rome Transplant Network.

Best Pract Res Clin Haematol. 2010 Jun;23(2):197-206. doi: 10.1016/j.beha.2010.05.007.

PMID:
20837331
17.

Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study.

Alessandrino EP, Della Porta MG, Bacigalupo A, Malcovati L, Angelucci E, Van Lint MT, Falda M, Onida F, Bernardi M, Guidi S, Lucarelli B, Rambaldi A, Cerretti R, Marenco P, Pioltelli P, Pascutto C, Oneto R, Pirolini L, Fanin R, Bosi A.

Haematologica. 2010 Mar;95(3):476-84. doi: 10.3324/haematol.2009.011429. Epub 2009 Nov 10.

18.

Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant.

Picardi A, Lanti A, Cudillo L, Cerretti R, Dentamaro T, De Angelis G, Ferraro A, Di Veroli A, Adorno G, Arcese W; Rome Transplant Network.

Transfusion. 2010 Feb;50(2):501-6. doi: 10.1111/j.1537-2995.2009.02439.x. Epub 2009 Oct 9.

PMID:
19821947
19.

Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options.

Natoli S, Fontana C, Favaro M, Bergamini A, Testore GP, Minelli S, Bossa MC, Casapulla M, Broglio G, Beltrame A, Cudillo L, Cerretti R, Leonardis F.

BMC Infect Dis. 2009 Jun 4;9:83. doi: 10.1186/1471-2334-9-83.

20.

A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient.

Beltrame A, Sarmati L, Cudillo L, Cerretti R, Picardi A, Anemona L, Fontana C, Andreoni M, Arcese W.

Int J Infect Dis. 2009 Nov;13(6):e488-92. doi: 10.1016/j.ijid.2009.01.020. Epub 2009 Apr 22.

21.

Rituximab in post allogeneic hematopoietic stem cell transplantation membranous nephropathy: a case report.

Vischini G, Cudillo L, Ferrannini M, Di Daniele N, Cerretti R, Arcese W.

J Nephrol. 2009 Jan-Feb;22(1):160-3.

PMID:
19229832
22.

Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation.

Tirindelli MC, Flammia G, Sergi F, Cerretti R, Cudillo L, Picardi A, Postorino M, Annibali O, Greco R, Avvisati G, Arcese W.

Transfusion. 2009 Jan;49(1):170-5. doi: 10.1111/j.1537-2995.2008.01934.x. Epub 2008 Oct 2.

PMID:
18954405
23.

Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion.

Cudillo L, Cerretti R, Baliva G, De Angelis G, Postorino M, Picardi A, Mirabile M, Lanti A, Cantonetti M, Arcese W.

Bone Marrow Transplant. 2009 Feb;43(4):347-8. doi: 10.1038/bmt.2008.333. Epub 2008 Oct 13. No abstract available.

PMID:
18850017
24.

Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.

Maurillo L, Buccisano F, Del Principe MI, Del Poeta G, Spagnoli A, Panetta P, Ammatuna E, Neri B, Ottaviani L, Sarlo C, Venditti D, Quaresima M, Cerretti R, Rizzo M, de Fabritiis P, Lo Coco F, Arcese W, Amadori S, Venditti A.

J Clin Oncol. 2008 Oct 20;26(30):4944-51. doi: 10.1200/JCO.2007.15.9814. Epub 2008 Jul 7.

PMID:
18606980
25.

WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Alessandrino EP, Della Porta MG, Bacigalupo A, Van Lint MT, Falda M, Onida F, Bernardi M, Iori AP, Rambaldi A, Cerretti R, Marenco P, Pioltelli P, Malcovati L, Pascutto C, Oneto R, Fanin R, Bosi A; Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Blood. 2008 Aug 1;112(3):895-902. doi: 10.1182/blood-2008-03-143735. Epub 2008 May 22.

26.

B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation.

Iori AP, Torelli GF, De Propris MS, Milano F, Pupella S, Gozzer M, Mancini F, Milani ML, Intoppa S, Cerretti R, Lucarelli B, Valle V, Malandruccolo L, Iannella E, Arleo E, Guarini A, Foà R.

Transplantation. 2008 Feb 15;85(3):386-90. doi: 10.1097/TP.0b013e3181622e36.

PMID:
18322430
27.

Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation.

Iori AP, Cerretti R, De Felice L, Screnci M, Mengarelli A, Romano A, Caniglia M, Cerilli L, Gentile G, Moleti ML, Giona F, Agostini F, Pasqua I, Perrone MP, Pinto MR, Grapulin L, Testi AM, Martino P, De Rossi G, Mandelli F, Arcese W.

Bone Marrow Transplant. 2004 Jun;33(11):1097-105.

PMID:
15094744
28.

Production of interferon-gamma by lymphocytes from paroxysmal nocturnal haemoglobinuria patients: relationship with clinical status.

Coluzzi S, Biffoni M, Pasqualetti D, Perrone MP, Vaglio S, Rahimi H, Arista MC, Laurenti L, Cerretti R, Girelli G.

Br J Haematol. 2004 Mar;124(5):685-90.

PMID:
14871257
29.

Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia: results in patients treated in second molecular remission or with molecularly persistent disease.

Lo-Coco F, Romano A, Mengarelli A, Diverio D, Iori AP, Moleti ML, De Santis S, Cerretti R, Mandelli F, Arcese W.

Leukemia. 2003 Oct;17(10):1930-3.

PMID:
14513040
30.

One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.

Mengarelli A, Iori AP, Romano A, Cerretti R, Cerilli L, De Propris MS, Fenu S, Moleti ML, De Felice L, Girelli G, Arcese W.

Haematologica. 2003 Mar;88(3):315-23.

31.

Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature.

Del Giudice I, Iori AP, Mengarelli A, Testi AM, Romano A, Cerretti R, Macrì F, Iacobini M, Arcese W.

Ann Hematol. 2003 Mar;82(3):189-92. Epub 2003 Feb 12. Review.

PMID:
12634956
32.
33.

Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.

Mauro FR, Gentile M, Mancini F, Giannarelli D, Guarini A, De Propriis MS, Cerretti R, Foa R.

Haematologica. 2002 Jun;87(6):602-8.

34.

Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.

Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.

Haematologica. 2002 Jan;87(1):52-8.

35.

Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemia.

Ricciardi MR, Petrucci MT, Gregorj C, Ariola C, Lemoli RM, Fogli M, Mauro FR, Cerretti R, Foà R, Mandelli F, Tafuri A.

Br J Haematol. 2001 May;113(2):391-9.

PMID:
11380404
36.
37.

Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features.

Mauro FR, Foa R, Cerretti R, Giannarelli D, Coluzzi S, Mandelli F, Girelli G.

Blood. 2000 May 1;95(9):2786-92.

38.

Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases.

Mauro FR, Foa R, Giannarelli D, Cordone I, Crescenzi S, Pescarmona E, Sala R, Cerretti R, Mandelli F.

Blood. 1999 Jul 15;94(2):448-54. Review.

Supplemental Content

Loading ...
Support Center